Ovation Science Inc. (FRA:0VH)
Germany flag Germany · Delayed Price · Currency is EUR
0.0140
-0.0005 (-3.45%)
Last updated: Feb 23, 2026, 8:20 AM CET

Revenue by Segment

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
Biotechnology (Startups)
113.22K61.93K138.15K224.95K750.01K
Biotechnology (Startups) Growth
82.80%-55.17%-38.58%-70.01%148.03%
Total
113.22K61.93K138.15K224.95K750.01K
Total Growth
82.80%-55.17%-38.58%-70.01%148.03%

Revenue by Geography

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
Canada
-33.74K1.21K43.12K750.01K
Canada Growth
-2690.90%-97.20%-94.25%148.03%
United States
113.22K28.19K136.95K146.65K-
United States Growth
301.59%-79.41%-6.62%--
Mexico
---35.18K-
Total
113.22K61.93K138.15K224.95K750.01K
Total Growth
82.80%-55.17%-38.58%-70.01%148.03%
Source: S&P Global Market Intelligence.